32 Biosciences
32 Biosciences is a microbiome medicine company developing precision diagnostics and therapeutics. They aim to revolutionize healthcare by defining, diagnosing, and restoring the functional health of the gut microbiome to prevent and treat chronic diseases. Their diagnostic platform uses AI/machine learning and mass spectrometry, and their therapeutic innovation is a potential non-antibiotic antimicrobial.
Funding Round:
Funding Amount: $6M
Date: 10-Jun-2025
Investors:
Markets: Healthtech, Biotech
HQ: Chicago, Illinois, United States
Founded: 2023
Website: https://www.32biosciences.com/
Leave a Comment
Comments
No comments yet.